Funding Support and Author Disclosures Dr Michos is supported by the Amato Fund in Women’s Cardiovascular Health at Johns Hopkins School of Medicine; and has served on the advisory board for Esperion, Novartis, and AstraZeneca. Dr Volgman is supported by the McMullan-Eybel Endowment Chair Fund at Rush University; has served as MSD/Bayer Virtual Global Advisory Board Member; has received support from the Bristol Myers Squibb Foundation Diverse Clinical Investigator Career Development Program (DCICDP); has served on the Novo Nordisk Virtual Advisory Board on Healthcare Disparities, Novartis Clinical Trial, and National Institutes of Health Clinical Trials; and has stock in Apple Inc. Dr Tamirisa has reported that she has no relationships relevant to the contents of this paper to disclose.